Analystreport

Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.

Oramed Pharmaceuticals Inc.  (ORMP) 
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm Check Earnings Report
US:NASDAQ Investor Relations: oramed.com/investors